← Leaderboards
Erik C Gunther
Renetx Bio, Inc.
$385,916
Attributed
$653,861
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $251.9K · FY2013–20$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$653,861 · 2
By mechanism
U01$401,917 · 1
R41$251,944 · 1
Top collaborators
- George Daniel Maynard3 shared
- Stephen M Strittmatter3 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAntibodiesDesignClinical TrialsS DiseaseComplexRunningProteinsSamplingUniversitiesSuccessBrainPre-ClinicalPathway InteractionsBaseAnalogCognitive FunctionAmyloid Beta-ProteinAssesCessation Of LifeCollaborationsCare BurdenApp-Ps1Cell Death
Grant awards (4)
Development of a tool to examine proteomic pathways in the AD brain$251,944
R41 · FY2020 · AG · contact PI
Small Molecule Development of PrPc Antagonists for the Treatment of Alzheimer's D$1
U01 · FY2015 · AG
Small Molecule Development of PrPc Antagonists for the Treatment of Alzheimer's D$200,958
U01 · FY2014 · AG
Small Molecule Development of PrPc Antagonists for the Treatment of Alzheimer's D$200,958
U01 · FY2013 · AG